Sequencing data on the long control region of human papillomavirus type 16
Maja Krajinovil31,2. and Ana Savi~ 2 l lnstitute of Biology and Human Genetics, Medical School, University of Belgrade and 2Institute of Molecular Genetics and Genetic Engineering, P.O. Box 794, 11 001 Belgrade, Yugoslavia A one base change (adenine at position 7861) in the long control region (LCR) of the prototype sequence of human papillomavirus type 16 was reported. With this correction, a new E2-binding site was revealed, 111 bp and 143 bp upstream from the TATA box and P97, respectively, and 105 bp downstream of the keratinocyte-dependent enhancer. An A to C mutation at position 41 was found in a patient with invasive carcinoma. This mutation falls within an E2-binding site.
Evidence accumulated so far suggests a causative role for human papillomaviruses (HPV) in cervical carcinogenesis (Boshart et al., 1984; Diirst et al., 1983; Pater & Pater, 1985; Shirasawa et al., 1987) . The HPV types most frequently associated with cervical carcinomas are 16 and 18 (Boshart et al., 1984; D~rst et al., 1983) . Usually, they are integrated into host genomes, but they can also be in an episomal form in cancer cells (Choo et al., 1987 b; Kennedy et al., 1987; Popescu et al., 1987; Tidy et al., 1989a) . The oncogenic region has been identified to be the early genes E6 and E7 and the long control region (LCR) of the viral DNA (Choo et al., 1987a; Smotkin & Wettstein, 1986; Wagatsuma et al., 1990) .
These genes are conserved in integrated viral DNA and by themselves can immortalize and transform cells in culture (Bedell et al., 1987 ; Kanda et al., 1988; Pirisi et al., 1987) . They are controlled by the E2 gene product, which can either activate or suppress them, by binding to ACC-N6-GGT sites within the LCR (Cripe et al., 1987; Phelps & Howley, 1987) . The E6 and E7 genes can also be regulated by cellular factors. Upstream of P97, the keratinocyte-dependent enhancer (KDE) and glucocorticoid-responsive element were identified (Cripe et al., 1987; Gloss et al., 1987) . Footprint analysis of the LCR showed 23 sites protected from DNase I by nuclear proteins (Gloss et al., 1989) . Thus a large part of the LCR might be involved in the regulation of transcription of the E6/E70RFs.
Analysing LCRs in biopsy samples, and comparing them to the published sequence of HPV-16 (Seedorf et al., 1985) , we found an adenine deletion at position 7861 in seven cervical biopsies with different histopathological findings. As the same one base deletion in the LCR was also found in cloned HPV-16, this change should be considered a correction of the prototype 0001-0163 © 1991 SGM sequence of HPV-16. We point it out because the corrected sequence includes a new E2-binding site, 143 bp upstream of P97, the promoter that controls transcription of the E6 and E7 genes.
Isolation of DNA from the biopsy specimen was performed by standard procedures, proteinase K digestion and phenol extraction (Old, 1986) . Biopsies were undertaken on the basis of abnormal cytological and colposcopical criteria.
The first screening for the presence of HPV-16 types in DNA of 174 cervical samples was performed by dot blot hybridization as described elsewhere (Anderson & Young, 1985) . The samples were further analysed by the polymerase chain reaction (PCR) using oligonucleotides that enable amplification of parts of the E1 region (positions 1120 to 1282), the E2 region (positions 2734 to 3872) and part of the LCR (positions 7763 to 75) in 13, 30 and 46 cases respectively. The reaction mixture (100 pl) contained 200 ng of target DNA, 100 pmol of each primer, 50 mM-KCI, 15 mM-MgC12, 100 mM-Tris-HC1 pH 8.3 and 0-1 ~ (w/v) gelatin, 200 ~tM of each dNTP and 2-5 units of thermostable DNA polymerase (Perkin Elmer Cetus) (Saiki et al., 1988) . The target DNA was amplified by the use of a Hybaid thermal cycler with the following profiles: 91 °C for 30 rain, 55 °C for 30 min, 72 °C for 30 min for 30 cycles when amplifying the E1 region; 94 °C for 1 min, 47 °C for 1 min, 72 °C for 2 rain for 25 cycles when amplifying the E2 region; and 94 °C for 1 min, 55 °C for 2 min, 72 °C for 3 min for 25 cycles when amplifying the LCR and genomic region. To detect DNA, 10 pl of the PCR reaction mix was loaded on a 2~ agarose gel. One nanogram of cloned HPV-16 DNA served as a positive control. As a negative control in each PCR, cervical DNA previously proven to be free of HPV-16 and capable of amplification was used (Fig. 1 d) . (Kerem et al., 1989) . The sequences of the primers were 5' CAATGTGATTGGTGA-AACTA 3' and 5' CTTCTCCTCCTAGACACCTGCAT 3'.
The primers used to amplify El, E2 and LCR should give fragments of 163, 1139 and 217 bp, respectively.
All HPV-16-positive samples showed amplification of E1 and LCR regions (Fig. 1 a, c) . In 17 cases, primers for the E2 region did not amplify the target sequence (Fig.  l b, lane 2) indicating an integration event with a disruption of this region, or a deletion covering the complementary sequence. As there is a possibility that some minor changes in the LCR, not detected by acrylamide electrophoresis (data not shown), could affect E6/E7 transcription, we decided to sequence some of the amplified LCRs. We randomly chose seven samples with different histopathological diagnosis, with and without the conserved E2 region.
The determination of the nucleotide sequence was performed either directly on PCR products or after cloning. When used directly (Green et al., 1989) , PCR fragments were purified by chloroform extraction and through Centricon 30 (Amicon), cut with Sinai and cloned into the Bluescribe vector, after blunt end ligation. Plasmid DNA was isolated from mixed colony populations (white plaques) previously proven to contain the expected LCR fragment by HindlII and EcoRI digestion (Sambrook et al., 1989a, b, c) . The DNAs were phenol-chloroform-extracted and ethanol-precipitated, and subsequently sequenced using T3 and T7 primers of the Bluescribe vector. The sequencing reaction was performed by the dideoxynucleotide chain termination method (Sanger et al., 1977) according to the manufacturer's instructions (Sequenase Verson 2.0 kit, United States Biochemical Corporation). The primers were the same as for the amplification of the LCR. The results were compared to the HPV-16 prototype sequence (Seedorf et al., 1985) .
The sequencing of PCR products covering part of the LCR from positions 7763 to 75 showed in one case of invasive carcinoma a point mutation, A to C, at position 41 within the N 6 c o r e of the second E2-binding site. All seven samples originating from different patients showed an adenine deletion at position 7861 (Fig. 2) . That was the reason to sequence the LCR from the original HPV-16 clone. Sequencing was performed with and without PCR amplification to avoid PCR artefacts. Fig. 3 . Cloned HPV-16 DNA and sequencing without PCR. The primers which were used corresponded to the primers for LCR amplification. The base deletion is indicated.
Both reactions showed the same one base deletion ( It is interesting to note that the lack of adenine at position 7861 formed a new E2 protein-binding site, ACC-N6-GGT, 105 bp downstream of the KDE, 111 bp and 143 bp upstream from the TATA box and P97, respectively (Fig. 4) . The observed deletion is within fp3u, a weak binding site for an unidentified HeLa nuclear protein from E2 protein-free extracts (Gloss et al., 1989) . Those extracts protected two more segments, termed fplu and fp2u, both of which also partially overlapped the two E2 protein-binding sites closest to P97. -16 (Seedorfet al., 1985) . Arrows indicate the amplified region. The position of the reported change, A(7861), and the newly formed E2-binding site are boxed. Three previously known E2-binding sites, ACC-N6-GGT , are underlined.
